T1	Participants 8 19	retapamulin
T2	Participants 544 696	METHODS Patients with SID were randomly assigned to retapamulin ointment 1% (twice daily [bid]) for 5 days, or oral cephalexin (500 mg bid) for 10 days.
T3	Participants 1161 1358	LIMITATIONS An imbalance existed in the number of patients with the clinical outcome "unable to determine" (15 retapamulin, 2 cephalexin), mainly because of their failure to attend the study visit.
